Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries

Background: Ustekinumab (UST) is an IL12/23 inhibitor utilized for altering inflammatory responses in inflammatory bowel disease (IBD). Clinical trials and case reports suggested that the effectiveness and safety of UST may differ among IBD patients in Eastern and Western countries. However, related...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, He, Wang, Fang, Wan, Jian, Su, Song, Shi, Yanting, Li, Xiaofei, Wu, Tong, Liang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004158/
https://www.ncbi.nlm.nih.gov/pubmed/36902681
http://dx.doi.org/10.3390/jcm12051894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004158/
https://www.ncbi.nlm.nih.gov/pubmed/36902681
http://dx.doi.org/10.3390/jcm12051894

Ejemplares similares